Citations 1
S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (ZUMA-7)
Sureda, Anna , Elsawy, Mahmoud , Ulrickson, Matthew L. , Perales, Miguel-Angel, Leslie, Lori A. , Kersten, M. J., Jacobson, Caron A. , Pagel, John M. , Wulf, Gerald , Johnston, P.B., Rapoport, Aaron P. , Peng, A., Du, L., Snider, J. T., Shah, J., Schupp, M., Cheng, P., To, C., Westin, Jason R. , Locke, Frederick L. , Dickinson, Michael , Ghobadi, Armin , Meerten, Tom van , Miklos, David B. , Farooq, Umar , Wannesson, Luciano , Gordon, Leo I. , Yang, Yin David , Oluwole, Olalekan O.
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 112-113
